Answer
Vismodegib (Erivedge) should not be used in children and adolescents under 18 because of safety concerns, and its safety and efficacy in this age group have not been established.
Sources for this answer
- Erivedge 150 mg hard capsulesRoche Products Limited · emc · SmPC §4.2 Posology and method of administration · Version 20Document updated
Sources checked